Boundless Bio, Inc. Common Stock
Biotechnology
Healthcare
BOLD
22.25 M shares
NASDAQ US
traded
03 Apr 2025
listed
no
open
1.45
52 week high
9.62
high
1.45
52 week low
1.38
low
1.32
growth
-87.80 %
previous Close
1.49
P/E ratio
market cap
79.89 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-16.51 M
2.75 %
eps
0.00 %
3.66 %
eps surprise
0.00 %
net profit margin
-1650900000.00 %
0.00 %
operating incoming
-18.72 M
3.49 %
net change in cash
8.85 M
42.30 %
cash on hand
40.21 M
28.22 %
cost of revenue
0.00 %
top top